Applied Dna Sciences Total Liabilities

Applied Dna Sciences posts a total liabilities of $1.5M as of March 2026. That compares with $2.8M in the prior-year period — down 46.5% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Applied Dna Sciences's total liabilities was $2.8M. The latest reading is $1.5M — a 46.5% year-over-year decrease (period ending March 2026). Use the history and growth charts on this page for a longer lookback.

Total Liabilities is one piece of Applied Dna Sciences's financial statement story. At $1.5M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for APDN's total liabilities usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Applied Dna Sciences's other metric pages and overview cover the third.

Judging Applied Dna Sciences against Materials peers is usually better than using a market-wide rule of thumb. Business models inside Materials are more comparable, which makes gaps in total liabilities easier to interpret. Start with $1.5M here, then scan peer and history charts to see if the gap is persistent.